circRNA basic information
circBase ID: hsa_circ_0020394
Name: hsa_circ_DOCK1
Synonym: -
Host Gene: DOCK1
Genomic location(hg19): chr10:128768965-128860040:+
Genomic location(hg38): chr10:126970701-127061776:+
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0004986
MONDO name: urinary bladder carcinoma
Disease details: bladder cancer
Disease DO ID:
4007
Disease MeSH ID:
-
Disease NCIt ID:
C4912
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

tumor tissues

Cell lines:

T24; UM-UC-3

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: NRBP1, Bax, Bcl-2, MMP2, MMP9
Associated microRNA: miR-328-3p
Biological function: circ_0020394 promotes bladder cancer cell viability, migration, invasion and glycolysis, inhibits apoptosis, and attenuates the antitumor effect of puerarin.
Molecular mechanism: circ_0020394 acts as a miR-328-3p sponge to increase NRBP1 expression in puerarin-treated bladder cancer cells.
Biological pathway or process:

apoptosis (inhibits); proliferation (promotes); migration (promotes); invasion (promotes); glycolysis (promotes); ceRNA regulation (other); drug resistance (promotes)

Detected method:
Q
Validation methods:

RT-qPCR; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; CCK8; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; In Vivo Animal Model

Clinical significance:

-

Description:

This study identifies circ_0020394 as a pro-tumor circRNA in bladder cancer cells that counteracts puerarin-induced suppression of viability, migration, invasion and glycolysis and puerarin-induced apoptosis. Mechanistically, circ_0020394 sponges miR-328-3p to increase NRBP1 expression, forming a circ_0020394/miR-328-3p/NRBP1 axis involved in the antitumor response to puerarin.

Confidence score:

0.5627

Other information
Title:

Puerarin Inhibits the Progression of Bladder Cancer by Regulating circ_0020394/miR-328-3p/NRBP1 Axis.

Journal: Cancer biotherapy & radiopharmaceuticals
Published: 2022
PubMed ID: 33016781
Study type:

biological research

Data availability: -
Code availability: -